IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS
The present invention regards certain IBAT inhibitors for the prophylaxis or treatment of a metabolic syndrome, obesity, a disorder of fatty acid metabolism, a glucose utilization disorder, or a disorder in which insulin resistance is involved such as diabetes mellitus type 1 or type 2 diabetes.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GILLBERG PER GORAN ANGELIN BO GRAFFNER HANS STARKE INGEMAR LINDQVIST ANN MARGRET |
| description | The present invention regards certain IBAT inhibitors for the prophylaxis or treatment of a metabolic syndrome, obesity, a disorder of fatty acid metabolism, a glucose utilization disorder, or a disorder in which insulin resistance is involved such as diabetes mellitus type 1 or type 2 diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20130132846A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20130132846A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20130132846A3</originalsourceid><addsrcrecordid>eNqNyj0KwkAQQOFtLES9w4C1oIlI2v2ZJUOSHZidPgRZK9FAvD-m8ADCg9d8W9ORswqUWnKkLBkiC6ig1QGTAkcYUK3jnjwEyiwBV2RTAMHeKgbwnAIpccp7s3lMz6Ucft-ZY0T17anM77Es83Qvr_IZO6nOl3qtaq43W_-nvj5aLoI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS</title><source>esp@cenet</source><creator>GILLBERG PER GORAN ; ANGELIN BO ; GRAFFNER HANS ; STARKE INGEMAR ; LINDQVIST ANN MARGRET</creator><creatorcontrib>GILLBERG PER GORAN ; ANGELIN BO ; GRAFFNER HANS ; STARKE INGEMAR ; LINDQVIST ANN MARGRET</creatorcontrib><description>The present invention regards certain IBAT inhibitors for the prophylaxis or treatment of a metabolic syndrome, obesity, a disorder of fatty acid metabolism, a glucose utilization disorder, or a disorder in which insulin resistance is involved such as diabetes mellitus type 1 or type 2 diabetes.</description><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131205&DB=EPODOC&CC=KR&NR=20130132846A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131205&DB=EPODOC&CC=KR&NR=20130132846A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GILLBERG PER GORAN</creatorcontrib><creatorcontrib>ANGELIN BO</creatorcontrib><creatorcontrib>GRAFFNER HANS</creatorcontrib><creatorcontrib>STARKE INGEMAR</creatorcontrib><creatorcontrib>LINDQVIST ANN MARGRET</creatorcontrib><title>IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS</title><description>The present invention regards certain IBAT inhibitors for the prophylaxis or treatment of a metabolic syndrome, obesity, a disorder of fatty acid metabolism, a glucose utilization disorder, or a disorder in which insulin resistance is involved such as diabetes mellitus type 1 or type 2 diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyj0KwkAQQOFtLES9w4C1oIlI2v2ZJUOSHZidPgRZK9FAvD-m8ADCg9d8W9ORswqUWnKkLBkiC6ig1QGTAkcYUK3jnjwEyiwBV2RTAMHeKgbwnAIpccp7s3lMz6Ucft-ZY0T17anM77Es83Qvr_IZO6nOl3qtaq43W_-nvj5aLoI</recordid><startdate>20131205</startdate><enddate>20131205</enddate><creator>GILLBERG PER GORAN</creator><creator>ANGELIN BO</creator><creator>GRAFFNER HANS</creator><creator>STARKE INGEMAR</creator><creator>LINDQVIST ANN MARGRET</creator><scope>EVB</scope></search><sort><creationdate>20131205</creationdate><title>IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS</title><author>GILLBERG PER GORAN ; ANGELIN BO ; GRAFFNER HANS ; STARKE INGEMAR ; LINDQVIST ANN MARGRET</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20130132846A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GILLBERG PER GORAN</creatorcontrib><creatorcontrib>ANGELIN BO</creatorcontrib><creatorcontrib>GRAFFNER HANS</creatorcontrib><creatorcontrib>STARKE INGEMAR</creatorcontrib><creatorcontrib>LINDQVIST ANN MARGRET</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GILLBERG PER GORAN</au><au>ANGELIN BO</au><au>GRAFFNER HANS</au><au>STARKE INGEMAR</au><au>LINDQVIST ANN MARGRET</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS</title><date>2013-12-05</date><risdate>2013</risdate><abstract>The present invention regards certain IBAT inhibitors for the prophylaxis or treatment of a metabolic syndrome, obesity, a disorder of fatty acid metabolism, a glucose utilization disorder, or a disorder in which insulin resistance is involved such as diabetes mellitus type 1 or type 2 diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20130132846A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T05%3A01%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GILLBERG%20PER%20GORAN&rft.date=2013-12-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20130132846A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |